Nobuto Okamoto
-
- Diet, Metabolism, and Disease 3
-
- Liver Disease Diagnosis and Treatment 11
- Neuroendocrine Tumor Research Advances 3
-
- Pancreatic and Hepatic Oncology Research 6
-
- Pancreatitis Pathology and Treatment 9
-
- Enzyme function and inhibition 4
-
- Lipid metabolism and disorders 3
-
- Endoplasmic Reticulum Stress and Disease 2
- Co-authors
- Saburo OnishiIsao NishimoriToshiji SaibaraMasafumi OnoKeisuke TaniuchiAkira HiroseKensuke MunekageKiyomi Fujikawa‐Adachi
- Journals
- Hepatology Research (4 papers)Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (2 papers)Liver International (1 paper)
- Partner nations
- JapanUnited Kingdom
In The Last Decade
Nobuto Okamoto
21 papers receiving 334 citations
Peers
Comparison fields: 5 of 56
- Endocrinology, Diabetes and Metabolism 79
- Hepatology 37
- Epidemiology 155
- Oncology 71
- Surgery 97
Countries citing papers authored by Nobuto Okamoto
This map shows the geographic impact of Nobuto Okamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuto Okamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuto Okamoto more than expected).
Fields of papers citing papers by Nobuto Okamoto
This network shows the impact of papers produced by Nobuto Okamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuto Okamoto. The network helps show where Nobuto Okamoto may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nobuto Okamoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 1 | |
| 2 | 2018 | 7 | |
| 3 | Elevated Expression of SCGB1D2 Predicts Unfavorable Prognosis in Patients with Pancreatic Ductal Adenocarcinoma | 2017 | 1 |
| 4 | 2017 | 11 | |
| 5 | 2013 | 50 | |
| 6 | 2013 | 14 | |
| 7 | 2012 | 12 | |
| 8 | 2011 | 14 | |
| 9 | 2011 | 19 | |
| 10 | 2010 | 19 | |
| 11 | 2006 | 47 | |
| 12 | 2005 | 19 | |
| 13 | 2005 | 15 | |
| 14 | Diminished cellular immune response to carbonic anhydrase II in patients with Sjögren's syndrome and idiopathic chronic pancreatitis. | 2004 | 8 |
| 15 | Expression of carbonic anhydrase-related protein VIII, X and XI in the enteric autonomic nervous system | 2003 | 5 |
| 16 | 2003 | 7 | |
| 17 | 2003 | 24 | |
| 18 | 2001 | 39 | |
| 19 | 2000 | 8 | |
| 20 | 1973 | 1 |
About Nobuto Okamoto
Nobuto Okamoto is a scholar working on Hepatology, Epidemiology and Oncology, having authored 23 papers that have together received 342 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (11 papers), Pancreatitis Pathology and Treatment (9 papers), Pancreatic and Hepatic Oncology Research (6 papers), Enzyme function and inhibition (4 papers), Neuroendocrine Tumor Research Advances (3 papers), Diet, Metabolism, and Disease (3 papers), Lipid metabolism and disorders (3 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (79 citations), Hepatology (37 citations) and Epidemiology (155 citations). Nobuto Okamoto has collaborated with scholars based in Japan and United Kingdom. Frequent co-authors include Saburo Onishi, Isao Nishimori, Toshiji Saibara, Masafumi Ono, Keisuke Taniuchi, Akira Hirose, Kensuke Munekage, Kiyomi Fujikawa‐Adachi, Keijiro Araki and Yuji Ohtsuki. Their work appears in journals such as Hepatology Research, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin, Liver International, Scientific Reports and Clinical Nephrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.